CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-16 | Zulueta Alfonso G Director | Grant or award · Stock Option (Right to Buy) | +223,719 | 223,719 | ||
| 2022-05-16 | Zulueta Alfonso G Director | Grant or award · Restricted Stock Units | +180,000 | 180,000 | ||
| 2022-05-16 | ENRIGHT ERIN S. Director | Grant or award · Stock Option (Right to Buy) | +223,719 | 223,719 | ||
| 2022-05-16 | ENRIGHT ERIN S. Director | Grant or award · Restricted Stock Units | +180,000 | 180,000 | ||
| 2022-05-02 | Marks Jason M. EVP,Chief Global Legal Officer | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2022-04-12 | Mikhail Karim President and CEO | Option exercise | +71,734 | 102,765 | ||
| 2022-04-12 | Mikhail Karim President and CEO | Shares withheld for taxes | −20,631 | $3.35 | $69K | 82,134 |
| 2022-04-12 | Mikhail Karim President and CEO | Option exercise · Restricted Stock Units | −71,734 | 143,466 | ||
| 2022-02-28 | Berg Aaron EVP, President US | Option exercise | +16,333 | 392,084 | ||
| 2022-02-28 | Berg Aaron EVP, President US | Option exercise · Restricted Stock Units | −16,333 | 16,333 | ||
| 2022-02-28 | Kalb Michael Wayne SVP and CFO | Option exercise | +16,333 | 256,960 | ||
| 2022-02-28 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −6,213 | $3.27 | $20K | 250,747 |
| 2022-02-28 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −16,333 | 16,333 | ||
| 2022-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise | +16,333 | 502,420 | ||
| 2022-02-28 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −5,508 | $3.27 | $18K | 496,912 |
| 2022-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −16,333 | 16,333 | ||
| 2022-02-04 | Berg Aaron EVP, President US | Grant or award · Stock Option (Right to Buy) | +131,700 | 131,700 | ||
| 2022-02-04 | Berg Aaron EVP, President US | Grant or award · Restricted Stock Units | +103,700 | 103,700 | ||
| 2022-02-04 | Kalb Michael Wayne SVP and CFO | Grant or award · Stock Option (Right to Buy) | +131,700 | 131,700 | ||
| 2022-02-04 | Kalb Michael Wayne SVP and CFO | Grant or award · Restricted Stock Units | +103,700 | 103,700 |
Page 20 of 67 · 1,339 trades